Search

Displaying results 5691 - 5700 of 10000 in total
  1. Drug

    Indole-3-Glycerol Phosphate

    go.drugbank.com/drugs/DB04143
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  2. Drug

    Bromopyruvate

    go.drugbank.com/drugs/DB17135
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    AMG-222

    go.drugbank.com/drugs/DB06011
    Experimental

  4. Drug

    Allovectin-7

    go.drugbank.com/drugs/DB17439
    Investigational

    Allovectin-7 or allovectin-7(r) is a lipid complex that contains the DNA sequences encoding HLA-B7 and beta-2 microglobulin. … It was discontinued after it failed to improve the objective response rate or overall survival versus first-line chemotherapy in malignant melanoma.[A255207]

  5. Drug

    Trifluoperazine

    go.drugbank.com/drugs/DB00831
    Approved

    A phenothiazine with actions similar to chlorpromazine. It is used as an antipsychotic and an antiemetic.

    Products: AA PHARMA TRIFLUOPERAZINE TABLET 1 mg, AA PHARMA TRIFLUOPERAZINE TABLET 5 mg
  6. Drug

    Bromochlorosalicylanilide

    go.drugbank.com/drugs/DB13696
    Experimental

    Categories: Antifungals for Topical Use, Antifungals for Dermatological Use
  7. Drug

    NVP-LEQ-506

    go.drugbank.com/drugs/DB12857
    Investigational

    LEQ506 has been used in trials studying the treatment of Advanced Solid Tumors, Recurrent or Refractory Medulloblastoma, and Locally Advanced or Metastatic Basal Cell Carcinoma.

  8. Drug

    Mesosulfuron-methyl

    go.drugbank.com/drugs/DB15184
    Experimental

    Mesosulfuron-methyl is under investigation in clinical trial NCT01118117 (A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery).

  9. Drug

    PL-3994

    go.drugbank.com/drugs/DB15355
    Investigational

    PL-3994 is under investigation in clinical trial NCT01304628 (Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma).

  10. Drug

    Apazunersen

    go.drugbank.com/drugs/DB16981
    Investigational

    Apazunersen is an antisense oligonucleotide designed to target and inhibit the expression of UBE3A-AS. It is being investigated for the treatment of Angelman Syndrome.[L46772]